<DOC>
	<DOC>NCT01820728</DOC>
	<brief_summary>This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene citrate treatment. The study is conducted with following methods: open label, active-controlled, randomized, parallel group, comparative.</brief_summary>
	<brief_title>A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-FÂ®</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<criteria>WHO group II Clomiphene citrate resistance BMI: 17~29 kg/m^2 Irregular menstrual cycle Normal blood concentration of FSH, E2, prolactin and TSH Uncontrolled endocrine disease Ovarian cystic tumor which are NOT related to PCOS Severe endometriosis Chronic cardiovascular disease, liver complaint</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>